Receive Breaking News updates as they occur
NEW YORK (AP) — Stocks are mostly unchanged in morning trading Thursday as investors sift through a handful of earnings reports. Drug company Mylan rose, but Signet Jewelers and Dollar General fell after the retailers reported quarterly results that disappointed investors.
The embattled manufacturer of EpiPens said Thursday it would help extreme allergy sufferers meet the costs of the life-saving devices after a five-fold price hike sparked outrage. Mylan NV, which holds a near-monopoly on the manufacture of the epinephrine injectors, said it would expand existing programs to defray out-of-pocket costs but did not say it would lower prices. After a series of price hikes, a pack of two of the devices sells for more than $600, compared to less than $100 in 2007, when Mylan bought the rights to the technology.